Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Tens of millions of pounds in investment is being provided by the group of firms which includes AstraZenecaa and Pfizer ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
are depressant drugs used to treat anxiety, panic attacks and sleep disorders, among other conditions. “If you take benzodiazepines for a long period of time, it can cause dementia,” Hasan said.
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...
A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...